---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-016171"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2023-09-29T23:59:59+00:00"
generated_at: "2026-06-10T06:47:42.996402+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Capricor raises $23M in registered direct offering of stock and warrants

## Summary
- Gross proceeds ~$23M from 4,935,621 shares plus warrants at $4.66/unit.
- Warrants exercisable at $5.70/share for 7 years, beginning 6 months after issuance.
- Investors include Nippon Shinyaku and Highbridge Capital Management.
- Net proceeds to fund R&D, manufacturing, working capital; expected to fund HOPE-3 Phase 3 topline data readout.

## SEC filing metadata
- accession: 0001558370-23-016171
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2023-09-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000155837023016171/0001558370-23-016171-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000155837023016171/capr-20230929x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-016171
- JSON: https://secwatch.observer/filing/0001558370-23-016171.json
- Plain text: https://secwatch.observer/filing/0001558370-23-016171.txt

## Key facts
- Material Agreements
  CAPRICOR THERAPEUTICS, INC. entered into Purchase Agreement with certain institutional investors valued at approximately $23 million (effective 2023-09-29).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: approximately $23 million
  - Effective: 2023-09-29
  source text: On September 29, 2023, Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Registered Offering”), an aggregate of (a) 4,935,621 shares of common stock, $0.001 par value per share, of the Company (the “Common Stock”), (the “Shares”) and (b) warrants to purchase 4,935,621 shares of the Company’s common stock (the “Warrants”) to the Purchasers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837023016171/0001558370-23-016171-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.